senior director, antibody engineering at Mediar Therapeutics - Cambridge, MA, US
Chief Medical Officer
Contact Jeffrey Bornstein
Senior Scientist
Contact Erin Devine
Associate Scientist
Contact Ruoyu Zhuo
Scientist II
Contact Katherine Lamm
Scientist
Contact Saroj Nepal
Head of Pharmacology and Translational Sciences
Contact Christopher Espelin
Drugging the myofibroblast: a new approach to treating fibrosis.